BrainStorm Cell Therapeutics Aligns with FDA on Phase 3b NurOwn Clinical Trial CMC Aspects Read More »
iRegene Receives IND Approval from U.S. FDA to Start Clinical Trial for Parkinson’s Disease Read More »